1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
1,described Researchers Hospital General work the tau 
4,conducting Inc. Biogen BIIB US is tests preclinical understand to Idec TDP-43 potential its said as target a Altimari Shannon spokeswoman a company statement an diseases neurodegenerative Cambridge the e-mailed 
8,described Researchers Hospital General work the tau 
9,described Researchers Hospital General work the tau 
